Multi-Agb Capsules
Natural health product licensed in Canada
- Licence holder
- Second Wind Vitamins Inc.
- NPN or DIN-HM
- 80008972
- Status
- Active licence
- Licence date
- 12 December 2008
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Fer: up to 18 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 3.999 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 99.999 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Manganèse Source : Produit de chélation de manganèse et de PVH | 0.667 mg | 2,001 µg |
| Niacine Source : Acide nicotinique | 13.33 mg | Not calculated |
| Riboflavine Source : Riboflavine | 1.133 mg | 3,399 µg |
| Fer Source : Fumarate ferreux | 6 mg | 18,000 µg |
| Folate Source : Acide folique | 266.667 mcg | Not calculated |
| Vitamine E Source : Acétate de d-alpha-tocophéryle Potency : 10 UI | 6.7 mg AT | Not calculated |
| Calcium Source : Citrate de calcium | 33.333 mg | 99,999 µg |
| Vitamine C Source : Acide ascorbique | 30 mg | 90,000 µg |
| Magnésium Source : Oxyde de magnésium | 20 mg | 60,000 µg |
| Magnésium Source : Citrate de magnésium | 13.333 mg | 39,999 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 1.333 mg | 3,999 µg |
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 33.333 mcg | 99.999 µg |
| Iode Source : Iodure de potassium | 50 mcg | 150 µg |
| Thiamine Source : Mononitrate de thiamine | 1 mg | 3,000 µg |
Non-medicinal ingredients
Gélatine, Microcrystalline cellulose, silice, Stéarate de magnésium végétal
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A vitamin and mineral supplement for the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80008972
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.